BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

61.46

+1.55 (2.59%)

At close: Aug 6, 2026, 4:00 PM EDT

64.55

+3.09 (5.03%)

After-hours: Aug 6, 2026, 7:45 PM EDT

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	11,879	11,428	12,539	18,185	19,275	16,249
Market Cap Growth	2.71%	-8.86%	-31.05%	-5.66%	18.63%	1.96%
Enterprise Value	15,191	10,465	11,996	18,198	19,067	16,314
Last Close Price	61.46	59.43	65.73	96.42	103.49	88.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	162.17	33.02	29.74	110.83	137.99	-
Forward PE	10.01	12.37	17.86	38.98	39.00	85.79
PEG Ratio	0.34	0.65	0.72	1.07	0.86	2.66
PS Ratio	3.49	3.55	4.39	7.52	9.20	8.80
PB Ratio	1.88	1.88	2.22	3.67	4.19	3.81
P/TBV Ratio	15.17	2.07	2.48	4.14	4.81	4.39
P/FCF Ratio	16.09	15.76	25.72	290.64	350.82	77.76
P/OCF Ratio	13.86	13.80	21.89	114.18	109.58	53.36

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.46	3.25	4.20	7.52	9.10	8.84
EV/EBITDA Ratio	50.26	21.40	20.66	62.72	72.51	634.83
EV/EBIT Ratio	101.78	25.56	24.77	97.96	118.45	-
EV/FCF Ratio	20.58	14.44	24.61	290.85	347.03	78.07

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.56	0.10	0.11	0.22	0.24	0.25
Debt / EBITDA Ratio	13.85	1.22	1.02	3.75	4.12	41.99
Debt / FCF Ratio	5.67	0.82	1.22	17.37	19.71	5.16
Net Debt / Equity Ratio	0.52	-0.16	-0.10	0.00	-0.04	0.02
Net Debt / EBITDA Ratio	10.96	-1.97	-0.93	0.05	-0.79	2.54
Net Debt / FCF Ratio	4.49	-1.33	-1.11	0.21	-3.79	0.31
Asset Turnover	0.35	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.53	0.57	0.50	0.53	0.60	0.64
Quick Ratio	1.16	3.25	2.96	1.45	2.98	2.54
Current Ratio	2.39	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	1.18%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	0.76%	4.06%	5.52%	2.50%	2.46%	-1.18%
Return on Invested Capital (ROIC)	0.97%	5.78%	7.57%	3.53%	3.49%	-1.66%
Return on Capital Employed (ROCE)	1.77%	6.20%	8.04%	3.24%	2.86%	-1.52%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.61%	3.03%	3.36%	0.90%	0.72%	-
FCF Yield	6.21%	6.34%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.61%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%
Total Shareholder Return	-0.61%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%

SEC Filings: 10-K · 10-Q